BL
Benjamin Landry sold $141K of HCAT stock
Benjamin Landry, General Counsel of Health Catalyst, Inc. (HCAT), sold 99,478 shares of HCAT stock worth $141K, per an SEC Form 4 filed Nov 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 11, 2026, 2 days before it was made public.
HCAT has moved +5.6% since the trade date, from $1.43 to $1.51 (Nov 13, 2026 close).
- Traded
- Nov 11, 2026
- Disclosed
- Nov 13, 2026
- Filing delay
- 2 days
- Price since
- +5.6%
- Role
- General Counsel
- Source
- SEC Form 4